| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Common Stock | Options Exercise | $0 | +1,558 | +0.96% | $0.000000 | 164,020 | 21 Feb 2022 | Direct | F1 |
| transaction | BSX | Common Stock | Tax liability | $19,488 | -458 | -0.28% | $42.55 | 163,562 | 21 Feb 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Deferred Stock Units | Options Exercise | $0 | -1,558 | -50% | $0.000000 | 1,558 | 21 Feb 2022 | Common Stock | 1,558 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| F2 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant. |